Moderna to Update at 2021 J.P. Morgan Healthcare Conference

 Moderna, Inc.  (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO Stéphane Bancel will present an update on the Company and its pipeline of mRNA development programs at this year’s 39^th annual J.P. Morgan Healthcare Conference.

Mr. Bancel’s presentation will take place virtually on Monday, January 11^th, 2021 at 4:30 p.m. ET. A live webcast will be available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna’s website for 90 days following the presentation.

https://www.biospace.com/article/releases/moderna-to-provide-business-and-pipeline-updates-at-the-2021-j-p-morgan-healthcare-conference/